Artificial intelligence is reshaping healthcare—from chatbots that screen for depression to algorithms that flag tumors in scans. But with each new breakthrough comes a question that rarely makes headlines: who is making sure this technology is safe, fair, and accountable?

The World Health Organization (WHO) has just taken a decisive step to answer that question. By establishing a new WHO Collaborating Centre on AI for Health Governance at Delft University of Technology in the Netherlands, the agency is signaling that AI in medicine is too important—and too risky—to be left unregulated.

This move could mark a turning point in the way the world approaches AI governance in healthcare.

Why AI in Health Demands Oversight

Healthcare is not like e-commerce or social media. The stakes are higher. An error in an algorithm could mean:

• A misdiagnosis of cancer.
• A biased triage system that disadvantages certain populations.
• An opaque risk score used by insurers to deny coverage.

AI has the potential to revolutionize global health, but without oversight it could just as easily deepen inequities, erode trust, and even cause harm. The WHO’s new centre is designed to confront this challenge head-on.

What the New Centre Will Do

The WHO Collaborating Centre on AI for Health Governance will focus on creating and testing frameworks to ensure that AI is:

• Safe: Minimizing risks of error and unintended consequences.
• Fair: Preventing bias and ensuring equity across gender, race, and geography.
• Transparent: Demanding explainability and accountability in AI systems.
• Sustainable: Evaluating environmental and social impacts of large-scale AI use.

In short, it’s about building trustworthy AI—not just powerful AI.

Global Implications

The significance of WHO’s involvement cannot be overstated. As a global body, the WHO provides standards and guidance that shape healthcare policies in countries across the world.

• For low- and middle-income countries, WHO frameworks could provide guardrails to adopt AI responsibly without becoming testbeds for poorly regulated technology.
• For tech companies, it means that international oversight—not just self-regulation—may increasingly define the boundaries of what is acceptable.
• For patients and clinicians, it offers a pathway to trust AI not as a mysterious black box, but as a tool governed by principles of ethics and accountability.

Challenges Ahead

But establishing a governance framework is one thing; enforcing it is another. Key challenges include:

• Global diversity: AI trained on Western data often underperforms in other populations. Can governance adapt to local realities?
• Industry resistance: Some companies may resist transparency requirements, citing intellectual property.
• Rapid innovation: AI is evolving faster than regulation. How can frameworks remain relevant?

The success of this centre will depend not just on guidelines, but on real mechanisms for compliance, auditing, and enforcement.

A New Chapter for AI in Health

The WHO’s move is part of a broader recognition: AI in healthcare is not just a technical innovation—it’s a social, ethical, and political issue. Governance will be as crucial as the algorithms themselves.

If done well, this initiative could create a global benchmark for responsible AI, ensuring that technology serves patients rather than profits, equity rather than exclusion.

---

Final thought: AI in healthcare may be one of the 21st century’s most powerful tools. With the WHO now putting governance under the microscope, the world has a chance to ensure it’s also one of the most responsible.